CANADA: Adastra Holdings Ltd., a leading cannabis company focused on processing, adult-use and medical sales, organoleptic testing and analytical testing, is pleased to announce that the Company has received its Controlled Drug and Substances Dealer’s License on August 24, 2022. This license allows Adastra to process psilocybin and psilocin, the active compounds derived from psychedelic Read the full article... http://dlvr.it/SXYQMN
No comments:
Post a Comment